These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 18540183

  • 1. [The role of neuromelanin in Parkinson's disease--new concepts].
    Stepień K, Dzierzega-Lecznar A, Tam I.
    Wiad Lek; 2007; 60(11-12):563-9. PubMed ID: 18540183
    [Abstract] [Full Text] [Related]

  • 2. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 3. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis.
    Enochs WS, Sarna T, Zecca L, Riley PA, Swartz HM.
    J Neural Transm Park Dis Dement Sect; 1994 Nov; 7(2):83-100. PubMed ID: 7710667
    [Abstract] [Full Text] [Related]

  • 4. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z, Abrahams S, Bardien S, Kenyon C.
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [Abstract] [Full Text] [Related]

  • 5. New face of neuromelanin.
    Double KL, Halliday GM.
    J Neural Transm Suppl; 2006 Nov; (70):119-23. PubMed ID: 17017518
    [Abstract] [Full Text] [Related]

  • 6. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [Abstract] [Full Text] [Related]

  • 7. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T, Monje MHG, Kinsinger M, Bustos BI, Lubbe SJ.
    Mov Disord; 2023 Feb; 38(2):185-195. PubMed ID: 36350228
    [Abstract] [Full Text] [Related]

  • 8. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T.
    J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
    [Abstract] [Full Text] [Related]

  • 9. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.
    Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L.
    Prog Neurobiol; 2017 Aug; 155():96-119. PubMed ID: 26455458
    [Abstract] [Full Text] [Related]

  • 10. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB, Ben-Shachar D, Riederer P.
    J Neural Transm Suppl; 1994 Aug; 43():113-22. PubMed ID: 7884393
    [Abstract] [Full Text] [Related]

  • 11. Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target.
    Mitra R, Premraj L, Khoo TK.
    Parkinsonism Relat Disord; 2023 Jul; 112():105448. PubMed ID: 37236833
    [Abstract] [Full Text] [Related]

  • 12. In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease.
    Gonzalez-Sepulveda M, Compte J, Cuadros T, Nicolau A, Guillard-Sirieix C, Peñuelas N, Lorente-Picon M, Parent A, Romero-Giménez J, Cladera-Sastre JM, Laguna A, Vila M.
    Brain; 2023 Mar 01; 146(3):1040-1052. PubMed ID: 36717986
    [Abstract] [Full Text] [Related]

  • 13. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera A, Muñoz P, Steinbusch HWM, Segura-Aguilar J.
    ACS Chem Neurosci; 2017 Apr 19; 8(4):702-711. PubMed ID: 28233992
    [Abstract] [Full Text] [Related]

  • 14. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP.
    Mov Disord; 2011 Aug 01; 26(9):1633-8. PubMed ID: 21491489
    [Abstract] [Full Text] [Related]

  • 15. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J.
    FASEB J; 2005 Apr 01; 19(6):533-42. PubMed ID: 15791003
    [Abstract] [Full Text] [Related]

  • 16. Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology.
    Vila M, Laguna A, Carballo-Carbajal I.
    Autophagy; 2019 Nov 01; 15(11):2028-2030. PubMed ID: 31480882
    [Abstract] [Full Text] [Related]

  • 17. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
    Mandel S, Maor G, Youdim MB.
    J Mol Neurosci; 2004 Nov 01; 24(3):401-16. PubMed ID: 15655262
    [Abstract] [Full Text] [Related]

  • 18. Neuronal vulnerability in Parkinson's disease.
    Double KL.
    Parkinsonism Relat Disord; 2012 Jan 01; 18 Suppl 1():S52-4. PubMed ID: 22166454
    [Abstract] [Full Text] [Related]

  • 19. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, Hogan C, Sarkar S, Rokad D, Panicker N, Anantharam V, Kanthasamy AG, Kanthasamy A.
    Neurobiol Dis; 2016 Sep 01; 93():96-114. PubMed ID: 27151770
    [Abstract] [Full Text] [Related]

  • 20. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J.
    Biol Signals Recept; 2001 Sep 01; 10(3-4):224-53. PubMed ID: 11351130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.